Full text is available at the source.
Abstract
Acmopatide is being evaluated for its efficacy and safety in adults with type 1 diabetes and overweight/obesity.
- Acmopatide acts on specific receptors related to glucose regulation.
- The study focuses on adults diagnosed with type 1 diabetes who also have overweight or obesity.
- Efficacy refers to how well acmopatide may improve diabetes management.
- Safety assessments will determine any potential risks associated with acmopatide use.
Simplified